secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001801170-24-000063
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health FY 2023 net loss improves to $213.4M; Insurance MCR drops to 81.2%
--------------------------------------------------------------------------------

- Full-year 2023 net loss of $213.4M vs $339.6M in 2022; Insurance MCR improved to 81.2% from 91.8%.
- Adjusted EBITDA loss narrowed to $44.7M in 2023 from $290.4M in 2022.
- Q4 2023 revenue $510.3M; Insurance revenue grew 12% YoY to $303.1M.
- FY 2024 guidance: Insurance MCR 79%-83%; up to $20M Adjusted EBITDA profitability at the high end.
- Adjusted SG&A (non-GAAP) of $302.0M in FY 2023, down from $312.5M in FY 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000063/0001801170-24-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000063/clov-20240312.htm
  HTML page:      https://secwatch.observer/filing/0001801170-24-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer